EFFICACY OF OMALIZUMAB TREATMENT FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA

Journal Title: Pulmonologija ir alergologija - Year 2018, Vol 2, Issue 1

Abstract

Background. Chronic spontaneous urticaria is defined as itchy hives, lasting for 6 and more weeks, with or without angioedema. Part of the patients do not have a response to a standard therapy with H1 antihistamines even taking four times their licensed doses. Omalizumab is a monoclonal anti-IgE antibody, recommended as a most effective III step treatment for chronic, antihistamines resistant spontaneous urticaria. Aim. To evaluate effectiveness of omalizumab in chronic spontaneous urticaria. Methods. In this article we present aretrospective analysis of 22 patients with an antihistamine resistant chronic spontaneous urticaria, treated with omalizumab in Department of Immunology and Allergology of Hospital of Lithuania University of Health Sciences Kauno klinikos. Activity of the disease was evaluated using urticaria activity score (UAS7) before and after treatment with omalizumab. Results.Reduction of chronic urticaria symptoms (urticaria activity score decreased more than 50 percent) was observed in 18 patients (81.8%), seven patients (31.8%) had decreased symptoms after first injection of omalizumab, eight of the patients (47.1%) who had finished 6 month treatment course, had renewal of urticaria symptoms and the treatment was continued. Conclusion. Omalizumab markedly reduce urticaria activity in patients with antihistamine-resistant chronic spontaneous urticaria. Omalizumab did not lose effectiveness after its reintroduction in treatment of relapsed chronic spontaneous urticaria.

Authors and Affiliations

Margarita Paulauskaitė, Ieva Bajoriūnienė, Jūratė Staikūnienė, Edita Gasiūnienė, Simona Kašinskaitė, Brigita Šitkauskienė

Keywords

Related Articles

PRINCIPLES OF DIAGNOSTIC IMAGING OF ACUTE PULMONARY INFECTIONS

Pulmonary infections are not only among the most common clinical situations, encountered in outpatient and inpatient clinical care, that have high impact on patient health status, treatment and outcomes, b...

MECHANOBIOLOGY IN STRUCTURAL LUNG CELLS AND THE IMPORTANCE OF IT’S CHANGES IN ASTHMA

Mechanobiology is an emerging field of science at the interface of biology and engineering that focuses on how physical forces and changes in the mechanical properties of cells and tissues contribute to development, cell...

FIBROBRONCHOSCOPY IN THE DIAGNOSIS OF LUNG DISEASES

Flexible bronchoscopy is an endoscopic method, which visually identified abnormalities within the airway, mucosa of trachea and bronchi. Since the 1970s, flexible bronchoscopy has begun to be w...

EXTRACELLULAR MATRIX AND ITS ROLE IN ASTHMA

Today, scientists have a lot of data about the extracellular matrix, but it's still underdeveloped the changes of pathogenesis in different illness. Therefore, the interaction between the structural cells of the cells an...

Lithuanian guidelines on evaluation and treatment of severe asthma in adults, 2017.

Lithuanian guidelines on evaluation and treatment of severe asthma in adults, 2017.

Download PDF file
  • EP ID EP502106
  • DOI -
  • Views 115
  • Downloads 0

How To Cite

Margarita Paulauskaitė, Ieva Bajoriūnienė, Jūratė Staikūnienė, Edita Gasiūnienė, Simona Kašinskaitė, Brigita Šitkauskienė (2018). EFFICACY OF OMALIZUMAB TREATMENT FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA. Pulmonologija ir alergologija, 2(1), 38-42. https://europub.co.uk/articles/-A-502106